Related Experiment Video
Updated: Feb 24, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
How much is too much? Two contrasting cases of excessive vitamin D supplementation
Sollip Kim1, Laura D Stephens2, Robert L Fitzgerald2
1Department of Laboratory Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea.
Insights
Individual responses to high-dose vitamin D vary significantly. Even with prolonged intake of supraphysiologic vitamin D levels, toxicity symptoms depend on patient-specific factors, not just concentration.
Area of Science:
- Endocrinology
- Clinical Pharmacology
- Nutritional Science
Background:
- Hypervitaminosis D is a condition of excessive vitamin D levels.
- This report details two distinct cases of vitamin D toxicity.
Observation:
- Patient 1, a 75-year-old man, experienced symptomatic hypercalcemia, cardiac injury, and elevated vitamin D (243 ng/ml) from daily ergocalciferol (vitamin D2) and calcium-citrate for one year.
- Patient 2, a 60-year-old woman, had very high vitamin D (479 ng/ml) from daily cholecalciferol (vitamin D3) for over 10 months but remained asymptomatic.
Findings:
- These cases highlight the wide variability in individual responses to prolonged supraphysiologic vitamin D concentrations.
- Defining a specific toxic threshold for vitamin D is challenging due to differing patient outcomes.
Implications:
- Patient pharmacodynamics, or how an individual's body processes a drug, significantly influence the clinical effects of high-dose vitamin D therapy.
- Clinical management of vitamin D supplementation requires consideration of individual patient variability.
Background:
In this report, we describe 2 contrasting cases of hypervitaminosis D.
Case Presentation:
Patient 1 was a 75-y old man who developed symptomatic hypercalcemia (peak serum calcium concentration of 15.3mg/dl; reference range: 8.5-10.6mg/dl), cardiac injury, and a high total serum vitamin D concentration of 243ng/ml (30-80ng/ml) as a result of daily consumption of prescribed 50,000IU ergocalciferol (vitamin D2) and 500mg calcium-citrate for 1y. Patient 2 was a 60-y old woman who consumed 40,000IU of cholecalciferol (vitamin D3) daily for >10months with a peak total serum vitamin D concentration of 479ng/ml (30-80ng/ml), but did not present with symptoms related to vitamin D toxicity.
Conclusion:
These cases demonstrate that individual responses to supraphysiologic concentrations of vitamin D for extended periods of time vary widely, and that defining a toxic concentration of this vitamin is difficult. The different outcomes in these two patients, despite months of high-dose vitamin D therapy, demonstrates that individual patient pharmacodynamics determine clinical sequelae.
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Vitamins
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Drug Toxicity: Risk factors
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...